Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany
· Delayed Price · Currency is EUR 1.060
-0.040 (-3.64%)
Apr 28, 2026, 11:06 PM CET
ETR:MAK Revenue
Maternus-Kliniken Aktiengesellschaft had revenue of 59.30M EUR in the half year ending June 30, 2025, with 16.89% growth. This brings the company's revenue in the last twelve months to 116.17M, up 6.87% year-over-year. In the year 2024, Maternus-Kliniken Aktiengesellschaft had annual revenue of 114.00M with 11.43% growth.
Revenue (ttm)
116.17M
Revenue Growth
+6.87%
P/S Ratio
0.19
Revenue / Employee
73.02K
Employees
1,591
Market Cap
22.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 114.00M | 11.70M | 11.43% |
| Dec 31, 2023 | 102.31M | -4.39M | -4.12% |
| Dec 31, 2022 | 106.70M | -4.74M | -4.25% |
| Dec 31, 2021 | 111.44M | -2.86M | -2.50% |
| Dec 31, 2020 | 114.30M | -10.13M | -8.14% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.10B |
| Siemens Healthineers AG | 23.30B |
| Bayer Aktiengesellschaft | 45.58B |
| Fresenius SE & Co. KGaA | 22.87B |
| DocCheck AG | 55.32M |
| Pentixapharm Holding AG | 526.00K |
| MeVis Medical Solutions AG | 16.06M |
| aap Implantate AG | 12.16M |